Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine.
D031841:Aconitum; D000404:Ajmaline / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001381:Azepines / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004285:Dogs; D004562:Electrocardiography; D004837:Epinephrine; D006327:Heart Block / Q000188:drug therapy; D008297:Male; D010042:Ouabain; D013610:Tachycardia / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D001381:Azepines; D001565:Benzoates; D000404:Ajmaline; D010042:Ouabain; D004837:Epinephrine